Literature DB >> 17313608

Relation of cortisol levels and bone mineral density among premenopausal women with major depression.

O Altindag1, A Altindag, M Asoglu, M Gunes, N Soran, Z Deveci.   

Abstract

We aimed to investigate the relationship between cortisol levels and bone mineral density (BMD) among premenopausal women with major depression. We compared BMD, plasma cortisol, osteocalcin and C-telopeptide (CTx) levels of 36 premenopausal women with major depression with 41 healthy women who were matched for age and body mass index. Osteocalcin and CTx were used for the evaluation of bone turnover. The clinical diagnosis of major depression was made by using the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. The 21-item Hamilton Rating Scale for Depression was used for the assessment of depressive symptoms. In comparison with the controls, the mean BMD of the depressed women was significantly lower at the lumbar spine and at all sites of the proximal femur (p = 0.02, 0.01). Plasma cortisol levels were significantly higher in depressive patients than in controls (p = 0.001). Osteocalcin was lower and CTx was higher in the patient group than in controls (p = 0.04, p = 0.008). Lumbar and femur BMD scores were negatively correlated with cortisol levels in the patient group. Major depression had important effects on BMD and bone turnover markers. Depression should be considered among risk factors for osteoporosis in premenopausal women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17313608     DOI: 10.1111/j.1742-1241.2006.01276.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  31 in total

Review 1.  Depression and osteoporosis: a research synthesis with meta-analysis.

Authors:  G Cizza; S Primma; M Coyle; L Gourgiotis; G Csako
Journal:  Horm Metab Res       Date:  2010-05-07       Impact factor: 2.936

Review 2.  Bone health and back pain: what do we know and where should we go?

Authors:  A M Briggs; L M Straker; J D Wark
Journal:  Osteoporos Int       Date:  2008-08-21       Impact factor: 4.507

Review 3.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 4.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

5.  Associations between Maternal Hormonal Biomarkers and Maternal Mental and Physical Health of Very Low Birthweight Infants.

Authors:  June Cho; Xiaogang Su; Vivien Phillips; Diane Holditch-Davis
Journal:  Asian Pac Isl Nurs J       Date:  2016

6.  Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.

Authors:  Sifat Maria; Rebekah M Samsonraj; Fahima Munmun; Jessica Glas; Maria Silvestros; Mary P Kotlarczyk; Ryan Rylands; Amel Dudakovic; Andre J van Wijnen; Larry T Enderby; Holly Lassila; Bala Dodda; Vicki L Davis; Judy Balk; Matt Burow; Bruce A Bunnell; Paula A Witt-Enderby
Journal:  J Pineal Res       Date:  2018-01-17       Impact factor: 13.007

Review 7.  Depression and osteoporosis: epidemiology and potential mediating pathways.

Authors:  B Mezuk; W W Eaton; S H Golden
Journal:  Osteoporos Int       Date:  2007-09-01       Impact factor: 4.507

Review 8.  Harmful effects of functional hypercortisolism: a working hypothesis.

Authors:  Giacomo Tirabassi; Marco Boscaro; Giorgio Arnaldi
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa.

Authors:  Elizabeth A Lawson; Daniel Donoho; Karen K Miller; Madhusmita Misra; Erinne Meenaghan; Janet Lydecker; Tamara Wexler; David B Herzog; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

10.  Affective Disorders, Bone Metabolism, and Osteoporosis.

Authors:  Briana Mezuk
Journal:  Clin Rev Bone Miner Metab       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.